Cargando…

Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique()

Among the 60 or so various cannabinoids which are present in cannabis sativa indica, terpenophenols are mainly found, including delta-9-trans tetrahydrocannabinol (Δ9-THC) which is the major psychoactive ingredient. Over the last decade, due to the emergence of e-commerce and the continuous investig...

Descripción completa

Detalles Bibliográficos
Autor principal: Kintz, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161525/
https://www.ncbi.nlm.nih.gov/pubmed/32300253
http://dx.doi.org/10.1016/j.banm.2020.04.003
_version_ 1783522969540100096
author Kintz, P.
author_facet Kintz, P.
author_sort Kintz, P.
collection PubMed
description Among the 60 or so various cannabinoids which are present in cannabis sativa indica, terpenophenols are mainly found, including delta-9-trans tetrahydrocannabinol (Δ9-THC) which is the major psychoactive ingredient. Over the last decade, due to the emergence of e-commerce and the continuous investigations by pharmaceutical groups to identify new active molecules, synthetic cannabinoids have been proposed. These compounds, under the generic name “spices” have chemical structures very different from that of Δ9-THC, but share the same CB1 and CB2 receptors. They are mimics of Δ9-THC with much powerful pharmacological effects, including thus more deterrent side-effects, and enhanced windows of detection. All these drugs are controlled. This means that they have to be tested in human biological specimens to document abuse. The aim of this mini-review is to present what has been described in the scientific literature according to the available specimens (blood, urine, saliva, sweat, hair and exhaled breath), focussing on the current advantages and limitations of each test.
format Online
Article
Text
id pubmed-7161525
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher l'Académie nationale de médecine. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71615252020-04-16 Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique() Kintz, P. Bull Acad Natl Med Revue Générale Among the 60 or so various cannabinoids which are present in cannabis sativa indica, terpenophenols are mainly found, including delta-9-trans tetrahydrocannabinol (Δ9-THC) which is the major psychoactive ingredient. Over the last decade, due to the emergence of e-commerce and the continuous investigations by pharmaceutical groups to identify new active molecules, synthetic cannabinoids have been proposed. These compounds, under the generic name “spices” have chemical structures very different from that of Δ9-THC, but share the same CB1 and CB2 receptors. They are mimics of Δ9-THC with much powerful pharmacological effects, including thus more deterrent side-effects, and enhanced windows of detection. All these drugs are controlled. This means that they have to be tested in human biological specimens to document abuse. The aim of this mini-review is to present what has been described in the scientific literature according to the available specimens (blood, urine, saliva, sweat, hair and exhaled breath), focussing on the current advantages and limitations of each test. l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2020-06 2020-04-16 /pmc/articles/PMC7161525/ /pubmed/32300253 http://dx.doi.org/10.1016/j.banm.2020.04.003 Text en © 2020 l'Académie nationale de médecine. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Revue Générale
Kintz, P.
Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique()
title Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique()
title_full Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique()
title_fullStr Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique()
title_full_unstemmed Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique()
title_short Cannabis et cannabinoïdes de synthèse. À propos de leur détection biologique()
title_sort cannabis et cannabinoïdes de synthèse. à propos de leur détection biologique()
topic Revue Générale
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161525/
https://www.ncbi.nlm.nih.gov/pubmed/32300253
http://dx.doi.org/10.1016/j.banm.2020.04.003
work_keys_str_mv AT kintzp cannabisetcannabinoidesdesyntheseaproposdeleurdetectionbiologique